CALCA and colitis: In experiments conducted on a mouse model of colitis, the knockout of CGRP or the administration of CGRP antagonists resulted in increased susceptibility to colitis in the mice, thereby indirectly reinforcing the anti-inflammatory properties of CGRP [141].